Clinical Trials Browser

INDUSTRY × Hematologic Neoplasms × eprenetapopt × Clear all

NCT00900614 2019-07-31

Safety Study of APR-246 in Patients With Refractory Hematologic Cancer or Prostate Cancer

Phase 1 Completed

GenitourinaryOther hematologic neoplasm

Prostatic Neoplasms, Hematologic Neoplasms